10. Share Capital | 10. SHARE CAPITAL During the year ended February 28, 2017: In March 2016, the Company issued 500,000 units at a price of $0.10 per unit for a total of $50,000. Each unit consists of one common share of the Company and one common share purchase warrant, with each warrant being exercisable into one additional share at an exercise price of $0.40 for a period of three years. The proceeds for this issuance were received in the year ended February 29, 2016 and on the issuance of these units, the Company allocated $500 to share capital and $49,500 to the warrant liability. In May 2016, the Company issued 353,521 common shares with a fair price of $0.10 per share for a total of $35,352 to settle accounts payable of $95,584 (CAD$123,733). As a result, the Company recorded a gain on settlement of debt of $60,232. In May 2016, the Company issued 200,000 units with a fair price of $0.21 per share in regards to the secured convertible debenture (Note 8). Each unit consists of one common share of the Company and one common share purchase warrant. Each warrant is exercisable to purchase one common share at a price of $0.40 per share for a period of two years. The warrants were determined to be derivatives. At issuance date, the fair value of the common shares and warrants was $73,621 with $41,000 allocated to share capital and $32,621 allocated to warrant liability. In September 2016, the Company issued 250,000 units at a price of $0.10 per unit for gross proceeds of $25,000. Each unit consists of one common share of the Company and one common share purchase warrant, with each warrant being exercisable into one additional share at an exercise price of $0.40 for a period of three years. Upon the issuance of these units, the Company allocated $250 to share capital and $24,750 to the warrant liability. In November 2016, the Company issued 400,000 common shares at a price of $0.25 per share for gross proceeds of $100,000. In January 2017, the Company issued 1,680,000 common shares with a fair price of $0.25 per share for a total of $420,000 to settle amounts due to a related party payable of $420,000. In January 2017, the Company issued 182,832 common shares with a fair price of $0.25 per share for a total of $45,708 to settle accrued liabilities of $76,100. As a result, the Company recorded a gain on settlement of debt of $30,392. In January 2017, the Company issued 121,888 common shares with a fair price of $0.25 per share for a total of $30,472 to settle amounts due to a related party of $30,472. In January 2017, the Company issued 236,571 common shares with a fair price of $0.38 per share for a total of $89,897 to settle accounts payable of $59,143. As a result, the Company recorded a loss on settlement of debt of $30,754. In January 2017, the Company issued 400,000 shares at a price of $0.25 per share for gross proceeds of $100,000. In February 2017, the Company issued 1,310,000 shares at a price of $0.25 per share for gross proceeds of $327,500. In February 2017, the Company issued 800,000 units at a price of $0.25 per unit for gross proceeds of $200,000. Each unit consists of one common share of the Company and one common share purchase warrant, with each warrant being exercisable into one additional share at an exercise price of $0.60 for a period of two years. Upon the issuance of these units, the Company allocated $800 to share capital and $199,200 to the warrant liability. In February 2017, the Company issued 1,073,698 units with a fair price of $1,509,022 in connection with the conversion of the convertible debenture (Note 8). Each unit consists of one common share of the Company and one common share purchase warrant, with each warrant being exercisable into one additional share at an exercise price of $0.40 for a period of two years. Upon the issuance of these units, the Company allocated $773,063 to share capital and $735,959 to the warrant liability. The Company paid a total of $43,225 in finders fees in connection with the private placements of equity financings during the year ended February 28, 2017. During the year ended February 29, 2016: In August 2015, the Company issued 22,222 common shares at CAD$0.45 for gross proceeds of $7,606 (CAD$10,000) in subscriptions for a private placement. In January 2016, the Company issued 125,000 common shares to a former officer for an employment contract entered in April 2015. The fair value of the shares issued was $37,500, and is included in salaries and benefits. Share Subscriptions Receivable As at February 28, 2017, the Company had $110,000 in share subscriptions receivable. Subsequent to the year end, the Company received the proceeds in full. Warrants Below is a summary of the common share purchase warrant transactions: Number of Warrants Weighted Average Exercise Price per Warrant $ Outstanding at February 28, 2015 and February 29, 2016 1,080,000 0.40 Issued 2,823,698 0.46 Expired (80,000) 1.50 Number of warrants at February 28, 2017 3,823,698 0.44 A summary of the common share purchase warrants outstanding and exercisable at February 28, 2017 is as follows: Exercise Price Number Outstanding Expiry Date $ 0.40 200,000 May 17, 2018 0.40 1,000,000 March 8, 2019 0.40 500,000 March 9, 2019 0.40 250,000 September 22, 2019 0.60 800,000 February 10, 2019 0.40 1,073,698 February 10, 2019 3,823,698 The weighted average exercise price is $0.44 and weighted average life of the warrants is 1.59 years. Stock Options The Companys Stock Option Plan allows a maximum 5,579,335 shares to be reserved for issuance under the plan. Options granted under the plan may not have a term exceeding 10 years and vesting provisions are at the discretion of the Board of Directors. In November 2015, the Company granted 2,600,000 stock options for a period of five years, valued at $0.04 per option for a total value of $107,172 calculated using the Black-Scholes Option Pricing Model assuming a life expectancy of five years, a risk free rate of 1.59%, a forfeiture rate of 0%, and volatility of 168%. During the year ended February 28, 2017, there were 300,000 stock options forfeited. A summary of the stock options outstanding and exercisable at February 28, 2017 is as follows: Exercise Price Number Outstanding and Exercisable Expiry Date Aggregate Intrinsic Value $ $ 0.10 2,300,000 November 3, 2020 1,403,000 As at February 28 The aggregate intrinsic value in the proceeding table represents the total intrinsic value, based on the Companys closing stock price of $0.71 per share as of February 28, 2017. |